Jordi Camps

Grup de recerca

Genòmica translacional del càncer colorectal Junior group leader (R3B)

jcamps@recerca.clinic.cat 0000-0003-2929-4228

Publicacions destacades

Centrosome reduction in newly-generated tetraploid cancer cells obtained by separase depletion

Autors:
Galofre, Claudia; Asensio, Elena; Ubach, Maria; Torres, Irianna M; Quintanilla, Isabel;

Castells, Antoni; Camps, Jordi.

Referència: Scientific Reports 2020.
Tetraploidy-Associated Genetic Heterogeneity Confers Chemo-Radiotherapy Resistance to Colorectal Cancer Cells

Autors:
Galofré C; Gönül Geyik Ö; Asensio E; Wangsa D; Hirsch D;

(...)

Mollà M; Yüce Z; Castells A; Ried T; Camps J .

Referència: Cancers 2020.
CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications

Autors:
Franch-Exposito, Sebastia; Bassaganyas, Laia; Vila-Casadesus, Maria; Hernandez-Illan, Eva; Esteban-Fabro, Roger;

(...)

Jose Lozano, Juan; Castells, Antoni; Maria Llovet, Josep; Castellvi-Bel, Sergi; Camps, Jordi.

Referència: Elife 2020.
The landscape of genomic copy number alterations in colorectal cancer and their consequences on gene expression levels and disease outcome

Autors:
Ried T; Meijer GA; Harrison DJ; Grech G; Franch-Expósito S;

Briffa R; Carvalho B; Camps J .

Referència: Molecular Aspects Of Medicine 2019.
Induced Chromosomal Aneuploidy Results in Global and Consistent Deregulation of the Transcriptome of Cancer Cells

Autors:
Wangsa, Darawalee; Braun, Rudiger; Stuelten, Christina H; Brown, Markus; Bauer, Kerry M;

(...)

Warner, Lidia; Upender, Madhvi; Hummon, Amanda B; Camps, Jordi; Ried, Thomas.

Referència: Neoplasia 2019.
The non-random landscape of somatically-acquired uniparental disomy in cancer

Autors:
Erola P; Torabi K; Miró R; Camps J;

Referència: Oncotarget 2019.
Quantitative analysis of somatically-acquired and constitutive uniparental disomy in gastrointestinal cancers

Autors:
Torabi, Keyvan; Erola, Pau; Isabel Alvarez-Mora, Maria; Diaz-Gay, Marcos; Ferrer, Queralt;

(...)

Jose Lozano, Juan; Miro, Rosa; Ried, Thomas; Ponsa, Immaculada; Camps, Jordi.

Referència: International Journal Of Cancer 2019.
Near-tetraploid cancer cells show chromosome instability triggered by replication stress and exhibit enhanced invasiveness.

Autors:
Wangsa, Darawalee; Quintanilla, Isabel; Torabi, Keyvan; Vila-Casadesus, Maria; Ercilla, Amaia;

(...)

Agell, Neus; Cimini, Daniela; Castells, Antoni; Ried, Thomas; Camps, Jordi.

Referència: Faseb Journal 2018.
Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer.

Autors:
Codony-Servat, Jordi; Cuatrecasas, Miriam; Asensio, Elena; Montironi, Carla; Martinez-Cardus, Anna;

(...)

Prat, Aleix; Rosell, Rafael; Garcia-Albeniz, Xabier; Camps, Jordi; Maurel, Joan.

Referència: British Journal Of Cancer 2017.
Transcription-dependent radial distribution of TCF7L2 regulated genes in chromosome territories

Autors:
Torabi, Keyvan; Wangsa, Darawalee; Ponsa, Immaculada; Brown, Markus; Bosch, Anna;

(...)

Calvo, Maria; Castells, Antoni; Miro, Rosa; Ried, Thomas; Camps, Jordi.

Referència: Chromosoma 2017.

Projectes destacats

Spatial distribution of genomic alterations in tumor buds and poorly differentiated clusters of colorectal cancer and their role in tumor immune evasion and metastasis

Investigador/a principal: Miriam Cuatrecasas Freixas, Jordi Camps Polo

Finançador: Instituto de Salud Carlos III

Codi: PI20/00863

Durada: 01/01/2021 - 31/12/2023
Nuevas estrategias para la estratificación del riesgo de recidiva en pacientes con cáncer de colon en estadio II: Integración de perfiles genómicos y carga tumoral ganglionar

Investigador/a principal: Miriam Cuatrecasas Freixas, Jordi Camps Polo

Finançador: Instituto de Salud Carlos III

Codi: PI17/01304

Durada: 01/01/2018 - 30/06/2022
Implicaciones de la heterogeneidad intratumoral en la respuesta al tratamiento de quimio-radioterapia neoadyuvante en pacientes con cáncer de recto

Investigador/a principal: Jordi Camps Polo

Finançador: Instituto de Salud Carlos III

Codi: FIS14 PI14/00783

Durada: 01/01/2015 - 01/01/2017
Identification of genetic determinants for the progression and response to treatment of colorectal cancer

Investigador/a principal: Jordi Camps Polo

Finançador: Instituto de Salud Carlos III

Durada: 01/01/2014 - 01/01/2016
Implications of copy number variants of the genome in the etiology and progression of colorectal cancer

Investigador/a principal: Jordi Camps Polo

Finançador: European Comission

Codi: CE-FP7-PPLE-2012-CIG

Durada: 01/01/2013 - 01/01/2017

Jordi Camps

Grup de recerca

Publicacions destacades

Projectes destacats

Spatial distribution of genomic alterations in tumor buds and poorly differentiated clusters of colorectal cancer and their role in tumor immune evasion and metastasis

Nuevas estrategias para la estratificación del riesgo de recidiva en pacientes con cáncer de colon en estadio II: Integración de perfiles genómicos y carga tumoral ganglionar

Implicaciones de la heterogeneidad intratumoral en la respuesta al tratamiento de quimio-radioterapia neoadyuvante en pacientes con cáncer de recto

Identification of genetic determinants for the progression and response to treatment of colorectal cancer

Implications of copy number variants of the genome in the etiology and progression of colorectal cancer

Subscriu-te a la Newsletter del Clínic